Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Marke
Nike Inc (NKE) reported Q1 revenue of $11.21B, missing estimates of $11.33B, but beat EPS estimates. Shares fell 9.5% in pre-market trading. Other stocks like Roze AI (RZAI) and Mangoceuticals (MGRX) also declined.
How this was made
The 30-second read
Why it matters
The revenue miss triggered a 9.5% pre‑market decline, indicating immediate market reaction.
Market read
Nike's earnings miss is a high‑impact event for the consumer sector and may influence related stocks.
What to watch
Nike's upcoming product launches and international demand could offset short‑term revenue concerns.
Background
Nike's Q1 earnings were released ahead of the broader consumer‑discretionary earnings season.
Ticker impact
Nike reported Q1 revenue of $11.21B, missing estimates, and shares fell 9.5% in pre‑market trading.
likely further downside as investors price in the revenue shortfall
The miss of $120M versus consensus is material for a large‑cap and triggered a double‑digit pre‑market drop.
Market effects
Footwear and apparel sector may see broader pressure as peers are compared to Nike's miss.
U.S. equity markets could open lower on consumer‑discretionary weakness.
Limited to markets tracking U.S. consumer stocks.
Counterpoint
Some investors may view the EPS beat as a buying opportunity if revenue guidance improves.
Key entities
- CompanyNike Inc.
Global athletic apparel and footwear manufacturer.



